Professor David (Ted) Garway-Heath, consultant ophthalmic surgeon at Moorfields Eye Hospital and International Glaucoma Association professor for glaucoma and allied studies at the Institute of Ophthalmology, University College London, has been appointed president of the European Glaucoma Society (EGS). Previously the vice president, Professor Garway-Heath was elected at the general assembly of the society’s members which met in London on 8 and 9 September 2017.
Professor Garway-Heath has worked at Moorfields since 1991, and as consultant ophthalmic surgeon since 2000. He was the principal investigator of the UK Glaucoma Treatment Study, a landmark trial in glaucoma management, and the first glaucoma trial to be published in The Lancet. He is also the inventor of the anatomical map, known as the Garway-Heath map, used worldwide in research into the structure-function relationship in glaucoma. He also pioneered a technique for analysing optic nerve head images, the ‘Moorfields Regression Analysis’, which contributed to the increasing use of imaging in the clinical management of glaucoma. This work was selected by University College London to showcase its excellence in medical research.
Author of nearly 200 scientific research papers, in 2016 Professor Garway-Heath was cited for the second time as one of the 100 most influential people in ophthalmology in The Ophthalmologist magazine’s power list.
Speaking on the announcement, Professor Garway-Heath said:
"I will build on the current strong and innovative leadership in pursuit of the patient focused EGS vision to promote the best possible well being and minimal glaucoma induced visual disability in individuals with glaucoma."
Founded in 1978, the EGS structures its practice around four key themes: innovation, education, communication and implementation.
Taking over from Professor Anja Tuulonen of Tampere University Hospital Finland, Professor Garway-Heath‘s appointment will take effect from 1 January 2018.
Was this information useful? Please rate the page.